Stelzer Laurie

CIK 00016443488 companiesCARMEL, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001644348

Recent Transactions

50 trades

Award
MBX Biosciences, Inc.$MBX
Stock option (right to buy)
2026-01-20+32,000→ 32,000 total
Award
Sionna Therapeutics, Inc.$SION
Non-Qualified Stock Option (right to buy)
2025-06-12+19,959→ 19,959 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2025-06-05+33,500→ 33,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-05-29+25,000→ 25,000 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2024-06-06+67,500→ 67,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2024-05-14+11,323→ 11,323 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2023-11-22+50,000→ 50,000 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-08-09$37.00/sh+22,297→ 102,312 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2023-06-08+21,500→ 21,500 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-06-02$37.06/sh−4,647→ 80,015 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-01-20+45,456→ 45,456 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-01-20+26,864→ 84,662 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2022-06-08+24,000→ 24,000 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option
2022-06-02−19,500→ 19,500 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-06-01+91,164→ 91,164 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-06-01+57,798→ 57,798 total
Other
ARENA PHARMACEUTICALS INC
Common Stock
2022-03-11−21,462→ 0 total
Disposition to Issuer
ARENA PHARMACEUTICALS INC
Employee Performance Restricted Stock Unit
2022-03-11−15,200→ 0 total
Disposition to Issuer
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2022-03-11−38,850→ 0 total
Disposition to Issuer
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2022-03-11−132,000→ 0 total
Other
ARENA PHARMACEUTICALS INC
Common Stock
2022-03-11−9,086→ 28,122 total
Other
ARENA PHARMACEUTICALS INC
Common Stock
2022-03-11−6,660→ 21,462 total
Award
ARENA PHARMACEUTICALS INC
Common Stock
2022-01-03+21,462→ 36,366 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2021-06-08+17,700→ 17,700 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option
2021-06-02−16,333→ 16,333 total
Tax Payment
ARENA PHARMACEUTICALS INC
Common Stock
2021-03-16$76.10/sh−4,356→ 14,904 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Common Stock
2021-03-16+12,600→ 19,260 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Performance Restricted Stock Unit
2021-03-16−12,600→ 0 total
Award
ARENA PHARMACEUTICALS INC
Employee Performance Restricted Stock Unit
2021-03-01+15,200→ 15,200 total
Award
ARENA PHARMACEUTICALS INC
Common Stock
2021-03-01+6,660→ 6,660 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2021-03-01+38,850→ 38,850 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2020-06-10+12,000→ 12,000 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-03-16+132,000→ 132,000 total
Award
ARENA PHARMACEUTICALS INC
Employee Performance Restricted Stock Unit
2020-03-16+6,300→ 6,300 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-22$21.83/sh−4,508→ 116,167 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2020-02-22−11,392→ 11,392 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-22+11,392→ 120,675 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-14+7,809→ 111,983 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2020-02-14−7,809→ 15,616 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-14$21.10/sh−2,700→ 109,283 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-12+11,262→ 108,068 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2020-02-12−11,262→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-12$20.00/sh−3,894→ 104,174 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2020-02-10+69,174→ 69,174 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2020-02-10+32,533→ 32,533 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-03$19.21/sh−8,275→ 96,806 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-02-03+23,119→ 105,081 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2020-02-03−23,119→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2019-06-15−6,875→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-06-15$15.73/sh−3,408→ 81,962 total

Stelzer Laurie

Recent Transactions

Companies

Recent Filings

Address